Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study
1 other identifier
observational
128
0 countries
N/A
Brief Summary
The objective of this study was to investigate whether infants with total serum bilirubin \> 450 umol/L in the neonatal period and no symptoms or no more than early acute bilirubin encephalopathy develop long term sequelae with impairment of motor development, hearing and executive function compared with a control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 14, 2012
CompletedFirst Posted
Study publicly available on registry
May 16, 2012
CompletedMay 16, 2012
May 1, 2012
10 months
May 14, 2012
May 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor development
Delayed motor development for children in the exposed group compared to children in the non-exposed group
Age 5-10 years
Study Arms (2)
Exposed group
Children age 5-10 years old who had a total serum bilirubin \> 450 umol/L in the neonatal period
Non-exposed group
Matched 1:1 to the exposed group on gender, age, gestational age and municipality of residence
Interventions
A standardised test developed to identify developmental difficulties in children.
Eligibility Criteria
All children born in Denmark in the period 01.01.2000 - 31.12.2005 with a gestational age \>= 35 weeks and a total serum bilirubin \> 450 umol/L and a matched control group of children
You may qualify if:
- Gestational age \> 35 weeks
- Total serum bilirubin \> 450 umol/L in the neonatal period
- Born in the period 01.01.2000 - 31.12.2005
You may not qualify if:
- Acute intermediate or advanced bilirubin encephalopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Vandborg PK, Hansen BM, Greisen G, Mathiasen R, Kasper F, Ebbesen F. Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study. Dev Med Child Neurol. 2015 Apr;57(4):378-84. doi: 10.1111/dmcn.12603. Epub 2014 Oct 29.
PMID: 25353277DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pernille Vandborg, MD, PhD
Børneafdelingen, Aalborg Sygehus, Denmark
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2012
First Posted
May 16, 2012
Study Start
March 1, 2010
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
May 16, 2012
Record last verified: 2012-05